Your browser doesn't support javascript.
loading
Clinical Utility of Highly Purified 10% Liquid Intravenous Immunoglobulin in Kawasaki Disease.
Oda, Takuya; Nagata, Hazumu; Nakashima, Yasutaka; Nanishi, Etsuro; Takada, Yui; Nishimura, Manao; Kubo, Eiji; Hatae, Ken; Ohga, Shouichi.
Afiliação
  • Oda T; Department of Pediatrics, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
  • Nagata H; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: dadan@pediatr.med.kyushu-u.ac.jp.
  • Nakashima Y; Department of Pediatrics, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
  • Nanishi E; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Takada Y; Department of Pediatrics, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
  • Nishimura M; Department of Pediatrics, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
  • Kubo E; Department of Pediatrics, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
  • Hatae K; Department of Pediatrics, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
  • Ohga S; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
J Pediatr ; 214: 227-230, 2019 11.
Article em En | MEDLINE | ID: mdl-31351682
Compared with a 5% intravenous immunoglobulin, a 10% intravenous immunoglobulin as the first-line treatment of Kawasaki disease significantly reduced the fever duration (10 vs 13 hours, P = .022) among the responders, and the interval to adjunctive therapy for nonresponders (47 vs 49 hours, P = .035). There were no severe adverse events.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Síndrome de Linfonodos Mucocutâneos Tipo de estudo: Observational_studies / Prognostic_studies Aspecto: Patient_preference Limite: Child, preschool / Female / Humans / Male Idioma: En Revista: J Pediatr Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Síndrome de Linfonodos Mucocutâneos Tipo de estudo: Observational_studies / Prognostic_studies Aspecto: Patient_preference Limite: Child, preschool / Female / Humans / Male Idioma: En Revista: J Pediatr Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos